Skip to content
10-Q

Quarterly Report

GALECTIN THERAPEUTICS INC GALT

0001140361-25-031039

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 7, 2025 64.06M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.45M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.33M sh
Shares Diluted Q2 2025 · Jun 30, 2024 62.23M sh
Shares Diluted Q2 2025 · Jun 30, 2024 62.1M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$14.29M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$20.44M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $13.77M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $15.12M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$118.89M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$113.98M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$104.79M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$83.87M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 −$44.37M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$61.96M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.77M
Current Liabilities Q2 2025 · Dec 31, 2024 $35.41M
Total Liabilities Q2 2025 · Jun 30, 2025 $132.77M
Total Liabilities Q2 2025 · Dec 31, 2024 $120.57M
Current Assets Q2 2025 · Jun 30, 2025 $15.43M
Current Assets Q2 2025 · Dec 31, 2024 $17.25M
Total Assets Q2 2025 · Jun 30, 2025 $15.6M
Total Assets Q2 2025 · Dec 31, 2024 $17.5M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.12
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.27
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.20
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.39
Eps Basic Q2 2025 · Jun 30, 2025 −$0.12
Eps Basic Q2 2025 · Jun 30, 2025 −$0.27
Eps Basic Q2 2025 · Jun 30, 2024 −$0.20
Eps Basic Q2 2025 · Jun 30, 2024 −$0.39
Sga Expense Q2 2025 · Jun 30, 2025 $1.36M
Sga Expense Q2 2025 · Jun 30, 2025 $2.78M
Sga Expense Q2 2025 · Jun 30, 2024 $1.48M
Sga Expense Q2 2025 · Jun 30, 2024 $3.07M
Rd Expense Q2 2025 · Jun 30, 2025 $3.26M
Rd Expense Q2 2025 · Jun 30, 2025 $9.75M
Rd Expense Q2 2025 · Jun 30, 2024 $9.81M
Rd Expense Q2 2025 · Jun 30, 2024 $17.87M
Net Income Q2 2025 · Jun 30, 2025 −$7.52M
Net Income Q2 2025 · Jun 30, 2025 −$17.15M
Net Income Q2 2025 · Jun 30, 2024 −$12.37M
Net Income Q2 2025 · Jun 30, 2024 −$23.86M
Operating Income Q2 2025 · Jun 30, 2025 −$4.63M
Operating Income Q2 2025 · Jun 30, 2025 −$12.52M
Operating Income Q2 2025 · Jun 30, 2024 −$11.29M
Operating Income Q2 2025 · Jun 30, 2024 −$20.94M